The Global Stethoscope Industry is forecasted for sales volume growth reaching US$ 1056 Million by 2033 | Future Market Insights, Inc.

Growing Frequency of Respiratory and Cardiovascular Conditions May Help Accelerate Market Growth. Stethoscope Market to Pick up Pace and achieve US$ 1056.0 million by 2033. Sales of Electronic Stethoscopes is high due to improved healthcare infrastructure and low electronic stethoscope pricing

NEWARK, Del, March 07, 2023 (GLOBE NEWSWIRE) -- By the end of 2033, the global Stethoscope Market to gain momentum US$ 1056.0 million, up from a value of US$ 612.9 million in 2023. Between 2023 and 2033, it is envisaged to strengthen at a CAGR of 5.6%, yielding an absolute dollar opportunity of US$ 38.4 million.

Increasing cases of cardiovascular and respiratory disorders, as well as an ageing population, are likely to strengthen the stethoscope industry. Adoption of technologically improved goods, such as Bluetooth communication with digital wireless hearing aids and stethoscope apps on smartphones, as well as different government efforts, are the other contributors promoting stethoscope market expansion.

Request Sample Report@

Accelerated Occurrence of Cardiovascular and Pulmonary Conditions

The growing people suffering from various cardiovascular and pulmonary diseases may have a significant impact on the future growth of the stethoscope industry. The bulk of cardiovascular disorders are associated with the type of sound made by the heart. Heart auscultation has long been used to detect early stages of cardiac malfunction.

The classic auscultation method necessitates extensive clinical expertise as well as extraordinary listening abilities. The emergence of technologically improved goods has enabled precise and rapid diagnosis. The above said aspects may play a role in the expansion of the digital stethoscopes market.

Better Digitization May Stimulate Demand for Digital Stethoscopes

Since a majority of these ailments require early detection in order to give prompt treatment, new electrical or digital stethoscopes have grown into a great alternative among healthcare stethoscope providers. The medical stethoscope industry's digitalization has had a serious influence on the stethoscope market.

To offer world-class diagnosis services, leading end users such as hospitals, home health care providers, and physicians have opted futuristic technologies in medical stethoscope instrument over conventional counterparts.

High Price of Modern Stethoscopes and the Dearth of Qualified Medical Professionals

Some potential drawbacks to stethoscope industry expansion exist. Stethoscopes, for example, may be more expensive due to the costs involved with futuristic features. This could result in higher healthcare bills.

Sales of digital stethoscopes may be hampered since a big portion of the world is still unable to afford vastly improved diagnostic equipment. A lack of understanding about how to employ digitized diagnostic instruments is a market disruptor. As a result, a paucity of credentialed healthcare workers may hamper medical stethoscope market growth.

Request Customization@

Key Takeaways

  • The acoustic stethoscope sector to thrive at a CAGR of 4.9% from 2023 to 2033 in the market by product category followed by amplifying stethoscope segment.
  • In the end-use category of the market physician office segment is to develop at a CAGR of 4.9% from 2023 to 2033.
  • The United States market is to reach US$ 369.4 million by 2033 developing at a CAGR of 4.7% between 2023 and 2033.
  • Chinese market to develop at a CAGR of 6.3% reaching US$ 55.4 million by 2033.
  • The Canadian market is to register US$ 42.5 million by 2033, gaining at a 5.7% CAGR between 2023 and 2033.
  • The German medical stethoscope market can advance at a CAGR of 4.3%, reaching US$ 50.9 million by 2033.
  • The market in the United Kingdom is to be worth $55.6 million by 2033, blooming at a CAGR of 6.3% between 2023 and 2033.

Analysis of the Stethoscope Market's Opponents

The stethoscope industry is extremely fragmented due to the existence of numerous stethoscope manufacturers operating both internationally and regionally. The competitive landscape comprises an examination of a few well-known worldwide and local enterprises with stethoscope market shares.

3M, Baxter International (Hill-Rom), GF Health Products Inc., Medline Industries Inc., American Diagnostic Corporation, Rudolf Riester GmbH, Cardionics Inc., ICU Medical, Heine Optotechnik GmbH & Co. KG, Eko Devices, Meditech Equipment Co., Ltd., and Contec Medical Systems are just a handful of the key stethoscope manufacturers.

Essential Competitive Innovations

  • Partnership – Caregility and Eko

Caregility, a telehealth platform firm, and Eko, a provider of telehealth stethoscopes, inked integration collaboration in August 2022. Caregility's cloud platform can communicate with Eko's smart stethoscopes and software.

This enables users of Caregility's iConsult app to do high-quality auscultation (listening for heart, lung, and other bodily sounds) on patients during a virtual physical exam.

  • Certification

In April 2022, Israeli firm Sanolla Ltd. gained 510(k) clearance from the United States Food and Drug Administration for their Voqx smart-infrared stethoscope. The first stethoscope certified by the United States Food and Drug Administration can detect infrasound and audible information to diagnose clinical problems is based on artificial intelligence (AI).

Get Full Access@

Key Stethoscope Manufacturers

  • 3M Company
  • American Diagnostic Corporation
  • Eko Devices Inc.
  • Welch Allyn, Inc.
  • Think Labs Medical LLC
  • Meditech Equipment Co., Ltd.
  • Contec Medical Systems
  • Cardionics, Inc. (3B Scientific GmbH)
  • A&D Medical
  • GF Health Products, Inc.
  • Rudolf Riester GmbH
  • Rijuven Corporation
  • eKuore

Use promo code >> FMITODAY to get flat 20% discount

Key Segments

By Product:

  • Acoustic Stethoscopes
  • Amplifying Stethoscopes
  • Digital Stethoscopes

By End Use:

  • Physicians' Offices
  • Home Care Settings
  • Hospitals
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa (MEA)

Table of Content

1. Executive Summary | Stethoscope Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

Ask An Analyst@

Explore FMI’s related ongoing Coverage on Healthcare Market Insights Domain

Brain Tumor Drugs Market Size: The brain tumor drugs market is estimated to record a 9.2% CAGR from 2023 to 2033. The market is likely to reach US$ 2.65 billion in 2023 and is expected to be worth US$ 6.30 billion in 2033.

Antibody Purification Service Market Share: Antibody purification is a critical step in the production of therapeutic antibodies, and its importance is reflected in the anticipated value pool of US$ 1 billion by the end of 2023 and a projected global demand of US$ 3 billion by 2033, marking a CAGR of 11% 

Bispecific Antibody Market Demand: The global biospecific antibody market is slated to reach a market value of US$ 500 million by the end of 2023, and eventually to US$ 1 billion by 2033, marking a CAGR of 7.2%.

Discrete Analyzers Market Growth: The global discrete analyzers market is expected to enjoy a valuation of US$ 1.5 Billion in the year 2023, and further expand at a CAGR of 5.2% to reach a valuation of ~US$ 2.6 Billion by the year 2033. 

Actinomycosis Market Opportunity: The actinomycosis market is anticipated to expand as society develops and looks for novel treatments for this ailment. In fact, it is expected that by 2033, global demand would be worth US$ 90 billion, growing at a CAGR of 6%.

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact Us:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
LinkedInTwitterBlogs | YouTube
For Sales Enquiries:
Old Source: Stethoscope Market Sales are expected to surpass US$ 914.1 Million by 2030: Future Market Insights, Inc.